News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Osiris Therapeutics, Inc. (OSIR) Announces Therésa K. Dixon As General Manager Of Market Access And Reimbursement


3/26/2014 7:20:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets, is pleased to announce the appointment of Therésa K. Dixon, to General Manager, Market Access and Reimbursement, reporting to Lode Debrabandere, Ph.D., President and Chief Executive Officer.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES